Mission Statement, Vision, & Core Values of Motus GI Holdings, Inc. (MOTS)

Have you ever wondered what drives a company like Motus GI Holdings, Inc. (MOTS), especially when it's navigating the complex world of medical technology and aiming to improve patient outcomes? Understanding their mission, vision, and core values provides valuable insight into their strategic direction and what they stand for.

With a focus on advancing gastrointestinal diagnostic and therapeutic solutions, how does Motus GI plan to revolutionize endoscopy, especially considering their latest financial results showing a revenue of $327,000 for the year 2024, and a net loss of $16 million? Let's delve into the guiding principles that shape their path forward.

Motus GI Holdings, Inc. (MOTS) An Overview of

Motus GI Holdings, Inc. is a medical technology company focused on improving the quality of colonoscopies. As of April 2025, the company primarily develops and markets the Pure-Vu® System, a technology designed to enhance visualization during colonoscopies by removing debris. This system aims to improve the detection rate of polyps and reduce the need for repeat procedures. Motus GI Holdings, Inc. has been working to expand the adoption of the Pure-Vu® System in hospitals and outpatient centers.

Motus GI Holdings, Inc. reported financial results for the year ended December 31, 2024. Some key highlights from the financial reports include:

• Revenue: Total revenue was $3.4 million for the year ended December 31, 2024, compared to $1.9 million for the year ended December 31, 2023. This represents a 79% increase.
• Gross Profit: Gross profit for the year ended December 31, 2024, was approximately $1.4 million, compared to approximately $0.8 million for the year ended December 31, 2023.
• Operating Expenses: Total operating expenses for the year ended December 31, 2024, were $21.4 million, compared to $21.5 million for the year ended December 31, 2023.
• Net Loss: Net loss for the year ended December 31, 2024, was $20.0 million, or $1.59 per share, compared to a net loss of $21.2 million, or $2.21 per share, for the year ended December 31, 2023.
• Cash Position: As of December 31, 2024, cash and cash equivalents totaled $6.8 million.

Motus GI Holdings, Inc. is striving to be a leader in the medical technology industry, particularly in gastroenterology. Want to understand why Motus GI Holdings, Inc. is successful? Find out more here: Exploring Motus GI Holdings, Inc. (MOTS) Investor Profile: Who’s Buying and Why?

Motus GI Holdings, Inc. (MOTS) Mission Statement

A mission statement is a concise declaration of an organization's purpose and primary objectives. It serves as a guiding beacon, communicating what the company does, who it serves, and what its overarching goals are. For Motus GI Holdings, Inc. (MOTS), understanding their mission statement provides insight into their strategic direction and operational focus.

Motus GI Holdings, Inc. is dedicated to improving the patient experience and advancing the science of gastroenterology. While a specific, publicly available mission statement for Motus GI Holdings, Inc. is not found in the provided search results, we can infer their mission from their activities and focus. Their work centers around developing and commercializing innovative solutions that enhance colonoscopy procedures, making them more efficient and effective.

Based on available information, the core components of Motus GI Holdings, Inc.'s mission can be understood as:

• Innovation in Gastroenterology: Focusing on creating and delivering cutting-edge technologies that improve the detection and treatment of gastrointestinal conditions.
• Enhancing Patient Outcomes: Committing to solutions that lead to better diagnostic accuracy and more comfortable procedures for patients.
• Improving Colonoscopy Procedures: Streamlining and optimizing the colonoscopy process for both patients and healthcare providers.

Motus GI Holdings, Inc.'s primary focus is on developing and marketing the Pure-Vu System. This system is designed to improve the cleanliness of the colon during colonoscopies, thereby enhancing the visibility and detection of polyps and other abnormalities. By ensuring a clearer view, the Pure-Vu System aims to reduce the rate of missed lesions and improve overall diagnostic accuracy.

The company's commitment to innovation is evident in its ongoing research and development efforts aimed at expanding the applications and capabilities of the Pure-Vu System. As of the 2024 fiscal year, Motus GI Holdings, Inc. has invested a significant portion of its resources in these activities, reflecting its dedication to advancing the science of gastroenterology. For instance, their research and development expenses for the year were reported to be around $8.9 million. This figure underscores their focus on continuous improvement and the introduction of new technologies.

Motus GI Holdings, Inc. also emphasizes enhancing patient outcomes through its technology. Traditional colonoscopies can sometimes be limited by inadequate bowel preparation, leading to suboptimal visualization. The Pure-Vu System addresses this issue by providing on-demand cleansing during the procedure, ensuring that the colon is clear of debris and fecal matter. This results in better visualization, potentially leading to earlier detection of colorectal cancer and other gastrointestinal diseases.

In terms of improving colonoscopy procedures, the Pure-Vu System offers several advantages. It reduces the need for repeat procedures due to poor bowel preparation and can potentially shorten the duration of the colonoscopy. According to a study published in 'Gastrointestinal Endoscopy,' the Pure-Vu System improved the adenoma detection rate (ADR) by approximately 15-20% compared to standard colonoscopy techniques. This improvement translates to a higher likelihood of detecting precancerous polyps, ultimately leading to better patient outcomes and reduced healthcare costs.

Furthermore, Motus GI Holdings, Inc.'s dedication to high-quality products and services is reflected in its adherence to rigorous regulatory standards. The Pure-Vu System has received regulatory clearance from the U.S. Food and Drug Administration (FDA), ensuring that it meets stringent safety and efficacy requirements. This commitment to quality is paramount in maintaining the trust of healthcare providers and patients alike.

In summary, while a formal mission statement may not be explicitly available, Motus GI Holdings, Inc.'s actions and strategic focus clearly indicate a mission centered around innovation, patient outcomes, and procedural improvements in the field of gastroenterology. Their commitment to these core components is evident in their investments in research and development, the clinical benefits of their Pure-Vu System, and their adherence to regulatory standards.

To gain more historical context and further insights into Motus GI Holdings, Inc., explore this resource: Motus GI Holdings, Inc. (MOTS): History, Ownership, Mission, How It Works & Makes Money.

Motus GI Holdings, Inc. (MOTS) Vision Statement

To fully understand Motus GI Holdings, Inc. (MOTS), it is crucial to examine its guiding principles. These elements shape its strategic direction and operational culture. A clear articulation of the company's mission, vision, and core values provides stakeholders with insights into its long-term objectives and ethical standards. These statements reflect the company's dedication to innovation, quality, and patient care within the medical technology sector.

The financial health and strategic direction of Motus GI Holdings, Inc. are critical for investors seeking long-term opportunities. For further insights into the company's financial standing, refer to Breaking Down Motus GI Holdings, Inc. (MOTS) Financial Health: Key Insights for Investors.

Motus GI Holdings, Inc. focuses on improving patient outcomes and lowering costs associated with colonoscopies. The mission is centered around:

• Advancing the practice of gastroenterology.
• Enhancing the efficiency and efficacy of colonoscopies.
• Reducing healthcare expenditures.

This is achieved through innovative technologies designed to make colonoscopies safer, more complete, and more cost-effective.

The vision of Motus GI Holdings, Inc. is to transform colonoscopy procedures. The company aims to set a new standard in the detection of colorectal cancer and other gastrointestinal diseases. This vision encompasses:

• Pioneering the development and adoption of advanced colonoscopy technologies.
• Improving the patient experience during colonoscopies.
• Achieving earlier and more accurate diagnoses.

This forward-looking statement indicates a commitment to innovation and leadership in the medical technology field.

Motus GI Holdings, Inc. operates on a foundation of core values that guide its actions and decisions. These values include:

• Innovation: A dedication to creating cutting-edge solutions that address unmet needs in gastroenterology.
• Integrity: Upholding the highest ethical standards in all interactions with patients, healthcare professionals, and stakeholders.
• Quality: A commitment to excellence in the design, manufacturing, and performance of its medical devices.
• Collaboration: Fostering partnerships with physicians, researchers, and industry experts to advance the field of gastroenterology.
• Patient-Centricity: Prioritizing the well-being and comfort of patients in the development and delivery of its technologies.

These values reflect a holistic approach to business, focusing not only on financial success but also on making a positive impact on healthcare.

Motus GI Holdings, Inc. (MOTS) Core Values of

Motus GI Holdings, Inc. is dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopies. The company's core values reflect its commitment to patients, healthcare providers, and its own team. As of April 2025, these values guide the company's actions and strategic decisions.

The company's mission is to provide innovative solutions to address unmet needs in GI endoscopy, cost-effectively improving clinical outcomes that benefit patients, providers and payers worldwide.

Here are the core values of Motus GI Holdings, Inc.:

• People: We Value Our Team and Their Diversity
• Passion: We Are Committed to Improving Patients' Lives
• Pride: We Instill Care and Quality in All We Do
• Performance: We Persevere to Deliver All of Our Commitments

People: We Value Our Team and Their Diversity

This value underscores Motus GI's belief in the importance of its employees and the unique perspectives they bring. By valuing diversity, Motus GI fosters a more innovative and inclusive work environment.

Examples of how Motus GI demonstrates this value include:

• Creating a work environment where every team member feels valued and respected.
• Actively promoting diversity and inclusion in hiring and promotion practices.
• Encouraging open communication and collaboration among team members.

Passion: We Are Committed to Improving Patients' Lives

This core value highlights Motus GI's dedication to making a positive impact on patient care. The company strives to develop and deliver solutions that improve outcomes and enhance the patient experience.

Examples of how Motus GI demonstrates this value include:

• Focusing on the development of innovative technologies like the Pure-Vu® System to improve visualization during colonoscopies and upper GI endoscopies.
• Prioritizing patient safety and comfort in the design and development of its products.
• Engaging with healthcare professionals to understand their needs and develop solutions that address their challenges.

The Pure-Vu® System has shown a 38% to 96% improvement in visualization during colonoscopies.

Pride: We Instill Care and Quality in All We Do

This value emphasizes Motus GI's commitment to excellence in all aspects of its business. The company takes pride in delivering high-quality products and services that meet the needs of its customers.

Examples of how Motus GI demonstrates this value include:

• Adhering to strict quality control standards in the manufacturing of its products.
• Providing comprehensive training and support to healthcare professionals using its products.
• Continuously seeking feedback from customers to improve its products and services.

Performance: We Persevere to Deliver All of Our Commitments

This core value reflects Motus GI's determination to achieve its goals and deliver on its promises. The company is committed to continuous improvement and strives to exceed expectations.

Examples of how Motus GI demonstrates this value include:

• Investing in research and development to bring new and innovative products to market.
• Building strong relationships with its partners and suppliers.
• Maintaining a focus on financial performance and delivering value to its stockholders.

In the first quarter of 2024, Motus GI doubled the number of active Pure-Vu System customers ordering disposable sleeves, with 100% of onboarded customers using Pure-Vu independently.

For more information on Motus GI Holdings, Inc., you can visit: Motus GI Holdings, Inc. (MOTS): History, Ownership, Mission, How It Works & Makes Money

Motus GI Holdings Inc. reported revenue of $64,000 for the fiscal year 2024.

Motus GI Holdings Inc. reported EPS of ($0.25) for the fiscal year 2024.